Advertisement

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 1269 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Evotec–Berenberg: investor conference, 201712 supply service Evotec presents at Berenberg European Conference in Surrey 2017-12-06
Evotec–Deutsche Börse: investor conference, 201711 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2017 2017-11-27
Evotec–Volks- und Raiffensenbanken (DE): investor conference, 201711 supply service Evotec attends DZ Bank Equity Conference 2017 in Ffm 2017-11-22
Cosmo Pharmaceuticals–Leucadia: investor conference, 201711 supply service Cosmo attends Jefferies London Healthcare Conference 2017-11-16
Evotec–Leucadia: investor conference, 201711 supply service Evotec AG presents at Jefferies 2017 Global Healthcare Conference London 2017-11-15
Evotec–Baader Bank: investor conference, 201709 supply service Evotec attends Baader Investment Conference 2017 in Munich 2017-09-20
Evotec–Berenberg: investor conference, 201709 supply service Evotec presents at 6th German Corporate Conference in Munich 2017-09-18
Evotec–Goldman Sachs: investor conference, 201709 supply service Evotec presents at 7th Annual Biotech Symposium in London 2017-09-18
Evotec–Bank of America: investor conference, 201709 supply service Evotec presents at BoAML Global Healthcare Conference London 2017-09-14
TrakCel–Image Box: public relations, 201709 supply service existent by Image Box PR 2017-09-07
Oxford Immunotec–Baird: investor conference, 201709 supply service Oxford Immunotec presents at Baird 2017 Global Healthcare Conference in NY 2017-09-06
Genoskin–Andrew Lloyd Associates: public relations, 201708 service existent by ALA 2017-08-29
Takeda–AstraZeneca: alpha-synuclein antibody, 201708– collab develpm + commerc of MEDI1341 in pre-clin developm for Parkinson’s disease 2017-08-29
Macrophage Pharma–Merck (DE): investment, 201708 financing round Series A extension with new investor Merk Ventures 2017-08-23
Medivir–BioCity (GB): compound management, 201708– supply service Medivir outsources compound management to BioAscent 2017-08-23
Micro-Sphere–Ramarketing: public relations, 201708– service by Ramarketing 2017-08-22
AstraZeneca–Ethris: mRNA-based therapeutics, 201708– collab research 5y w €25m upfront + funding + milestones using SNIM®RNA technology 2017-08-21
Oxford Genetics–Invesco: investment, 201708 investment round totalling £7.5m from Mercia Technologies + Invesco Perpetual 2017-08-21
Oxford Genetics–Mercia Technologies: investment, 201708 investment round totalling £7.5m from Mercia Technologies + Invesco Perpetual 2017-08-21
Oxford Genetics–Ramarketing: public relations, 201708 service existent by Ramarketing 2017-08-21
Oxford Genetics–SEVERAL: investment, 201708 investment round £7.5m from Mercia Technologies + Invesco Perpetual 2017-08-21
BerGenBio–Huntsworth: public relations, 201708 service existent by Citigate Dewe Rogerson 2017-08-18
Cambridge Epigenetix–NuGen: epigentic technologies, 201708– collab to combine technologies for epigenetics research 2017-08-15
Mestrelab Research–SpectralWorks: analytical instrument software, 201708– collab mutual reseller agreem for all respective NMR/MS s/w products 2017-08-15
Purdue Pharma–CellAct: cancer drug, 201708– acquisition ww developm + commerc rights to CAP7.1 by Mundipharma from CellAct 2017-08-14
IFM Therapeutics–BMS: investment, 201708– acquisition 100% for $300m upfront + up to $2.02b milestones 2017-08-03
RealHealthData–Linguamatics: text analysis s/w, 201708– collab use of I2E platform for text mining of RealHealthData patient narratives database 2017-08-03
Chiltern–LabCorp: investment, 201707– acquisition $1.2b in cash of Chiltern by LabCorp ANNOUNCED 2017-07-31
DiscoverX–Eurofins: investment, 201707– acquisition by Eurofins ANNOUNCED 2017-07-31
Aptuit–Evotec: investment, 201707– acquisition $300m in cash of Aptuit from Welsh, Carson, Anderson & Stowe ANNOUNCED 2017-07-30
iTeos Therapeutics–Consilium: public relations, 201707 service existent by CSC 2017-07-28
Loxo Oncology–Redx Pharma: BTK inhibitor, 201707 acquisition $40m upfront cash of Redx's BTK inhibitor drug development program 2017-07-28
AstraZeneca–Merck (US): cancer drugs, 201707– strategic oncology collab maximising combis of PARP + MEK inhibitors with PD-L1/PD1 medicines 2017-07-27
Complix–Huntsworth: public relations, 201707 service existent by Citigate Dewe Rogerson 2017-07-27
Evosciences–Danaher: mass spectrometer, 201707– distribution of Sciex MS systems with flexible finacing packages via Evosciences in Europe 2017-07-27
Storm Therapeutics–Evotec: drug discovery services, 201707– supply service expansion €na HTS + structural biology plus chemistry + new targets 2017-07-27
Jazz Pharmaceuticals–XL-protein: PASylation technology, 201707– license $2m upfront + funding + milestones + royalties to develop asparaginase drugs 2017-07-26
One Nucleus–Instinctif Partners: public relations, 201707– collab Instinctif joins the One Nucleus Partner Programme 2017-07-25
General Electric–Horizon Discovery: investment, 201707–acquisition $50m cash + $35m equity of GE Healthcare Dharmacon Inc by Horizon Discovery 2017-07-19
Horizon Discovery–General Electric: investment, 201707– issue of 13.06m shares $35m to GE as part of acquisition of Dharmacon resulting in 8.8% share 2017-07-19
Horizon Discovery–SEVERAL: investment, 201707 capital increase £80m placing 39.02m new shares at 205p/share ANNOUNCED 2017-07-19
Shire–Novimmune: therapeutic antibodies, 201707– license ww excl €na to bispecific antibody for hemophilia A 2017-07-18
Silence Therapeutics–FTI Consulting: public relations, 201707 service existent by FTI Consulting 2017-07-14
ABF–Genedata: bioinformatics, 201707– supply expansion use of Genedata Selector by AB Enzymes for decision support 2017-07-11
BioCity (GB)–Alto Marketing: public relations, 201707 service existent for BioAscent Discovery Ltd by Alto Marketing Ltd 2017-07-11
Freeline Therapeutics–Consilium: public relations, 201707 service existent by CSC 2017-07-10
Cellnovo–Consilium: public relations, 201707 service existentPR in UK by CSC 2017-07-07
Cobalt Light Systems–Agilent: investment, 201707 acquisition by Agilent for £40m in cash 2017-07-07
Cellnovo–SEVERAL: investment, 201707 capital increase €17.5m with 4.07m new shares at €4.3/share (discount of 27.2%) to institutional investors 2017-07-06
GSK–Exscientia: drug discovery, 201707– strategic collab pre-clinical research on up to 10 GSK targets 2017-07-02
Evotec–Censo Biotechnologies: stem cell technology, 201706–201905 strategic collab €na with Censo supplying iPS cell lines to Evotec 2017-06-28
LogicBio Therapeutics–Arix Bioscience: investment, 201706 financing round Series B totalling $45m incl lead investor Arix Bioscience 2017-06-27
LogicBio Therapeutics–LCF Rothschild: investment, 201706 financing round Series B totalling $45m incl new + co-investor EdRIP 2017-06-27
LogicBio Therapeutics–SEVERAL: investment, 201706 financing round Series B $45m led by Arix Bioscience + incl OrbiMed +EdRIP + Pontifax + SBI 2017-06-27
Mitoconix Bio–Arix Bioscience: investment, 201706 financing round Series A totalling $20m incl co-investor Arix Bioscience 2017-06-27
Mitoconix Bio–SEVERAL: investment, 201706 financing round Series A $20m led by Remiges Ventures + incl OrbiMed + Arix Bioscience + RMPG et al 2017-06-27
Electrical Geodesics–Philips: investment, 201706– acquisition £29m in cash of EGI by Philips for £1.054/share ANNOUNCED 2017-06-22
Evotec–Deutsche Bank: investor conference, 201706 supply service Evotec presents at dbAccess Berlin Conference 2017-06-21
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
Cell Medica–United Kingdom (govt): T cell therapy, 201706– acquisition rights €na to WT1-TCR cell therapy from CGT Catapult 2017-06-20
Debiopharm–Almac: kinase inhibitor, 201706– license ww excl to Wee-1 kinase inhibitor programme of Almac Discovery 2017-06-20
Novacyt–SEVERAL: investment, 201706 capital increase €3m net €2.8m w 3.53m new shares resulting in delution of 16% 2017-06-20
Parexel–Pamplona Capital: investment, 201706– acquisition $5b incl net debt in cash with $88.1/share ANNOUNCED 2017-06-20
Broughton Laboratories–Thermo Fisher: LC system, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
Broughton Laboratories–Thermo Fisher: mass spectrometer, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Biocartis–MRC Technology: molecular diagnostics, 201706– collab €na developm of liquid biopsy cancer tests on Idylla platform 2017-06-07
Cosmo Pharmaceuticals–Leucadia: investor conference, 201706 supply service Cosmo attends Jefferies Global Healthcare Conference 2017 in NY 2017-06-07
Grünenthal–AstraZeneca: zolmitriptan, 201706 acquisition ww rights excl JP to Zomig $200m upfront + $102m milestones by Grünenthal 2017-06-07
Arix Bioscience–Leucadia: investor conference, 201706 supply service Arix Bioscience presents at Jefferies Healthcare Conference in New York 2017-06-06
Cell Medica–Leucadia: investor conference, 201706 supply service Cell Medica presents at Jefferies Healthcare Conference in New York 2017-06-06
Merck (DE)–F-Star: antibody cancer drug, 201706– strategic collab to develop 5 bispecific antibodies incl lead asset FS118 2017-06-04
Bicycle Therapeutics–SEVERAL: investment, 201706 financing round Series B £40m led by new investor Vertex Ventures HC 2017-06-01
Arix Bioscience–Consilium: public relations, 201705 service existent by Consilium Strategic Communications 2017-05-31
Oxford Gene Technology–Sysmex: investment, 201705– acquisition €na of OGT by Sysmex 2017-05-31
Recipharm–Ramarketing: public relations, 201705 service existent by Ramarketing 2017-05-26
Harpoon Therapeutics–Arix Bioscience: investment, 201705 financing round Series B totalling $45m incl new + co-lead investor Arix Bioscience plc 2017-05-25
Harpoon Therapeutics–SEVERAL: investment, 201705 financing round Series B $45m Arix Bioscience + New Leaf Venture + Taiho Ventures + MPM Capital 2017-05-25
AstraZeneca–Genomic Vision: genomic technology, 201705– collab using FiberVision DNA combing to develop WEE1 kinase inhibitors 2017-05-23
CureVac–Informa: investor conference, 201705 supply service CureVac presents at BioEquity Europe 2017 in Paris 2017-05-22
Evotec–Informa: investor conference, 201705 supply service Evotec presents at BioEquity Europe 2017 in Paris 2017-05-22
Macrophage Pharma–Informa: investor conference, 201705 supply service Macrophage Pharma presents at BioEquity Europe 2017 in Paris 2017-05-22
Medigene–Informa: investor conference, 201705 supply service Medigene presents at BioEquity Europe 2017 in Paris 2017-05-22
Probiodrug–Informa: investor conference, 201705 supply service Probiodrug presents at BioEquity Europe 2017 in Paris 2017-05-22
Recordati–AstraZeneca: metoprolol, 201705– acquisition $300m commercial rights to Seloken + Logimax in Europe by Recordati 2017-05-22
TxCell–Informa: investor conference, 201705 supply service TxCell presents at BioEquity Europe 2017 in Paris 2017-05-22
Iterum Therapeutics–Arix Bioscience: investment, 201705 financing round Series B totalling $65m incl new + lead investor Arix Bioscience plc 2017-05-19
Iterum Therapeutics–SEVERAL: investment, 201705 financing round Series B $65m led by new investor Arix Bioscience plc 2017-05-19
Scancell–SEVERAL: investment, 201705 placing £5m (net £4.7m) of 50.5m shares at 10p/share 2017-05-11
BC Platforms–Debiopharm: investment, 201705 financing round Series B totalling $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
BC Platforms–SEVERAL: investment, 201705 financing round Series B $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
BC Platforms–Tesi (FI): investment, 201705 financing round Series B totalling $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
Exscientia–Huntsworth: public relations, 201705 service existent by Citigate Dewe Rogerson 2017-05-09
GammaDelta–Takeda: investment, 201705 equity investment as part of strategic collab incl excl option to acquire GammaDeltaTherapeutics 2017-05-09
Sanofi–Exscientia: drug discovery, 201705– strategic research collab up to €250m using AI for bi-specific small-moleulces for metabolic disease 2017-05-09
Takeda–GammaDelta: T cell therapy, 201705– strategic collab $100m funding by Takeda + Abingworth incl equity investm + option to acquire GDT 2017-05-09
Genetrix (ES)–SEVERAL: investment, 201705– capital increase up to €10m w rights offering + private placement Sygnis AG 2017-05-08
1 2 3 4 5 6 7 8 9 10 11 12 13  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 600x60px

» top

Advertisements

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 40 Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 3 Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px